Here's Friday's medtech news of note.
> Anthem Blue Cross Blue Shield, Blue Shield of California, and Blue Cross and Blue Shield of Alabama have issued a positive medical policy for Heartflow's noninvasive coronary artery disease test, the Heartflow FFRct Analysis, which uses CT images to create a 3D model of a patient's coronary arteries. Release
> Thermo Fisher set up a consortium in Europe to push the adoption of next-generation sequencing clinical research panels to help identify biomarkers associated with cancer immunotherapy. Release
> Hologic is rolling out its Brevera breast biopsy system, the first to combine tissue acquisition, real-time imaging, sample verification and advanced postbiopsy handling in one system. Release
> Baxter teams up with healthcare incubator Matter on products and technology based on patient-driven innovation. Release
> Abbott won reimbursement for its FreeStyle Libre glucose-monitoring system in Japan. Release
